Polymorphic CAG repeat in the androgen receptor gene in polycystic ovary syndrome patients

By                      

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1330-1334

Spandidos Publications

Access to resources Recommend Favorite

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

By Ferraldeschi Roberta  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1191-1198

Springer Publishing Company

Access to resources Recommend Favorite

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

By Fontein Duveken   Houtsma Daniel   Nortier Johan   Baak-Pablo Renee   Kranenbarg Elma   Straaten Tahar   Putter Hein   Seynaeve Caroline   Gelderblom Hans   Velde Cornelis   Guchelaar Henk-Jan  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 599-606

Springer Publishing Company

Access to resources Recommend Favorite

Relationship of ovarian volume with mean platelet volume and lipid profile in patients with polycystic ovary syndrome

By      

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1141-1144

Spandidos Publications

Access to resources Recommend Favorite

CYP2C19 genotype–phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity

By Burns K.   Goldthorpe M.   Porteus F.   Browett P.   Helsby N.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 651-655

Springer Publishing Company

Access to resources Recommend Favorite